Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Surveillance: Coronavirus Treatments With Sharfstein

Surveillance: Coronavirus Treatments With Sharfstein

FromBloomberg Surveillance


Surveillance: Coronavirus Treatments With Sharfstein

FromBloomberg Surveillance

ratings:
Length:
29 minutes
Released:
Apr 6, 2020
Format:
Podcast episode

Description

Charles Kantor, Neuberger Berman Long Short Fund Senior Portfolio Manager, is very bullish on America's recovery, saying there is more than enough federal stimulus for now. Joyce Chang, JPMorgan Chair of Global Research, says revisions on dividends and earnings will continue. Joshua Sharfstein, Johns Hopkins University Bloomberg School of Public Health Vice Dean for Public Health Practice and Community Engagement, says it's important to temper expectations about potential coronavirus treatments. Ted Alden, CFR Senior Fellow & Author of "Failure to Adjust: How Americans Got Left Behind in the Global Economy," says there are a lot of incentives now for countries to pursue more nationalist policies. Martijn Rats, Morgan Stanley Global Oil Strategist, says the oil market is trading at an unusually deep discount.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
Released:
Apr 6, 2020
Format:
Podcast episode

Titles in the series (100)

Tom Keene, Jon Ferro, Lisa Abramowicz, and Paul Sweeney have the economy and the markets "under surveillance" as they cover the latest in finance, economics and investment, and talk with the leading voices shaping the conversation around world markets.